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Evidence for substrate-assisted catalysis in
N-acetylphosphoglucosamine mutase
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Division of Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Correspondence: Daan M.F. van Aalten (dmfvanaalten@dundee.ac.uk)
N-acetylphosphoglucosamine mutase (AGM1) is a key component of the hexosamine
biosynthetic pathway that produces UDP-GlcNAc, an essential precursor for a wide
range of glycans in eukaryotes. AGM belongs to the α-D-phosphohexomutase metalloen-
zyme superfamily and catalyzes the interconversion of N-acetylglucosamine-6-phosphate
(GlcNAc-6P) to N-acetylglucosamine-1-phosphate (GlcNAc-1P) through N-acetylglucosa-
mine-1,6-bisphosphate (GlcNAc-1,6-bisP) as the catalytic intermediate. Although there is
an understanding of the phosphoserine-dependent catalytic mechanism at enzymatic
and structural level, the identity of the requisite catalytic base in AGM1/phosphoglucomu-
tases is as yet unknown. Here, we present crystal structures of a Michaelis complex of
AGM1 with GlcNAc-6P and Mg2+, and a complex of the inactive Ser69Ala mutant
together with glucose-1,6-bisphosphate (Glc-1,6-bisP) that represents key snapshots
along the reaction co-ordinate. Together with mutagenesis, these structures reveal that
the phosphate group of the hexose-1,6-bisP intermediate may act as the catalytic base.
Introduction
N-acetylphosphoglucosamine mutase (AGM1) catalyzes the interconversion of
N-acetylglucosamine-6-phosphate (GlcNAc-6P) to N-acetylglucosamine-1-phosphate (GlcNAc-1P) in
eukaryotes [1]. This enzyme is a member of the α-D-phosphohexomutase superfamily of enzymes that
catalyze intramolecular phosphoryl transfer on a range of phosphosugar substrates [2]. The reaction
catalyzed by AGM1 is the third step in the biosynthesis of UDP-GlcNAc from fructose-6-phosphate
in the hexosamine pathway [3]. UDP-GlcNAc is an important metabolite for many cellular processes.
In bacteria, it is the precursor of outer membrane lipopolysaccharide [4,5] and cell wall peptidoglycan
[6]. In eukaryotes, it is the precursor of GPI anchors [7] together with its role as sugar donor in many
glycosylation reactions including N-glycosylation and O-glycosylation [8,9]. In fungi, UDP-GlcNAc is
also the precursor of chitin and mannoproteins, which are essential components of the fungal cell
wall [3]. Knockout of any of the genes encoding enzymes of the UDP-GlcNAc pathway has been
demonstrated to be lethal in Saccharomyces cerevisiae, unless exogenous glucosamine or
N-acetylglucosamine is available [1,10,11]. Previously, AGM1 was shown to be an essential gene in
the human fungal pathogen Aspergillus fumigatus and has been proposed as a drug target [12].
However, there are no mechanism-inspired inhibitors of this family of enzymes due to a limited
understanding of their catalytic mechanisms.
The phosphohexomutase superfamily comprises two subfamilies separated by their ability to
operate on α-D-sugar 1-phosphates or β-D-sugar 1-phosphates. While the former family is distin-
guished by the phosphorylation of a conserved serine to give a stable phosphate monoester [2], the
latter uses a conserved aspartate as a nucleophile to form a transient phospho-enzyme intermediate
[13]. Some members of the phosphohexomutase superfamily, phosphoglucomutases, bacterial phos-
phoglucosamine mutases and yeast phosphoacetylglucosamine mutases share the common sequence
motif Ser/Thr-X-Ser-His-Asn-Pro [14,15]. Phosphorylation of these enzymes, shown to occur on the
serine at the third position in the sequence motif [16], is required for full activity; however, the
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enzymes are initially produced in an inactive, dephosphorylated form [17]. A hexose-1,6-bisphosphate has been
reported to be the phosphate donor in the activation process during catalysis that occurs via a ping-pong bi-bi
mechanism [14,16,18]. It has also been shown that the phosphoglucosamine mutase from Escherichia coli
autophosphorylates in vitro in the presence of [32P]ATP and the same was observed for phosphoglucosamine
mutases from other bacterial species, yeast N-acetylglucosamine-phosphate mutase, and rabbit muscle phospho-
glucomutase [17]. Several crystal structures complexed with phosphate mimics (e.g. triﬂuoromagnesate ‘MgF3
−’
and triﬂuoroberrylate ‘BeF3
−’) or phosphate together with phosphosugars have revealed the residues implicated
in substrate binding and catalysis, and revealed large conformational changes [2,13,19]. However, the identity
of the catalytic base for these enzymes is as yet unknown.
Here, we describe the crystallographic snapshots of A. fumigatus AGM1 (AfAGM1) that reveal large con-
formational changes accompanying phosphoryl transfer. Furthermore, the complexes, together with modelling
studies, suggest that the phosphate group of the reaction intermediate may act as the catalytic base during
catalysis. This increase in understanding of the reaction mechanism of this class of enzymes could be exploited
in the rational design of mechanism-inspired inhibitors.
Materials and methods
Mutagenesis
The previously published AfAGM1 GST fusion construct, pGEX-6P AfAGM1 [12], served as the template for
the generation of S69A and S507A amino acid substitutions by site-directed mutagenesis, using the mutagenic
oligonucleotides 50-GGATTGGCGTCATGGTCACTGCGGCTCATAATCCTGCCGAGGACAATGG-30 (S69A
forward), 50-CCATTGTCCTCGGCAGGATTATGAGCCGCAGTGACCATGACGCCAATCC-30 (S69A reverse),
50-GGGACGAAGCTTCGCTCGTGCAG7CTGGCACGGAAGATGCGGTGCGTG-30 (S507A forward) and 50-
CACGCACCGCATCTTCCGTGCCAGCTGCACGAGCGAAGCTTCGTCCC-30 (S507A reverse). Site-directed
mutagenesis was carried out following the QuikChange Site-Directed Mutagenesis protocol (Stratagene), using
the KOD HotStart DNA polymerase (Novagene). All plasmids were veriﬁed by sequencing using the University
of Dundee sequencing service.
Protein production and puriﬁcation
AfAGM1 and mutated forms were produced and puriﬁed as described previously [12]. Brieﬂy, the E. coli strain
BL21 (DE3) pLysS was used to produce the proteins and the puriﬁcation consisted of chromatographic steps,
with glutathione Sepharose 4B beads and a Superdex75 gel ﬁltration column (2.6 × 60 cm) (Amersham
Biosciences). Prior to gel ﬁltration, the GST from the fusion protein was cleaved by PreScission protease.
Crystallization, data collection, and structure determination
Crystals of the wild-type enzyme were grown in a mother liquor containing 20% PEG 1000 and 100 mM
HEPES (pH 7.25), as described previously [12]. The complex with GlcNAc-6P was obtained by soaking experi-
ments with the sugar and an excess of MgCl2. Crystals of the AfAGM1_S69A mutant co-crystallised with
15 mM Glc-1,6-bisP and 5 mM MgCl2 were obtained in several conditions: 0.2 M sodium thiocyanate, 20%
PEG 3350, and 0.1 M sodium bromide; 0.10 M glycine, 22% PEG 3350, and 0.2 M sodium thiocyanate; and a
ﬁnal condition with 0.16 M glycine, 16% PEG 3350, and 0.2 M sodium thiocyanate. The two complexes crystal-
lised after 2–3 days in the space group P212121 with differences in the unit cell dimensions with respect to the
wild type (Table 1). X-ray diffraction data were collected at the BM14 beam line of the European Synchrotron
Radiation Facility (ESRF, Grenoble, France). Single crystals were cryoprotected (15% glycerol plus the appropri-
ate mother liquor) and frozen in a nitrogen gas cooled to 100 K. Complete data sets were collected for the
GlcNAc-6P and Glc-1,6-bisP complexes. Data were processed with HKL2000 [20]. Both complexes were solved
by molecular replacement using a previously described structure of the wild-type enzyme in complex with mag-
nesium [12]. Reﬁnement was performed with REFMAC5 [21] and model building with COOT [22]. Ligand
structures and topologies were generated by PRODRG [23]. Models for ligands were not included until their
conformations were completely deﬁned by unbiased |Fo|− |Fc|, wcalc electron density maps. Pictures were gener-
ated using Pymol [24].
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Enzyme kinetics
To determine the phosphoglucose mutase and phophoglucosamine mutase activities of AGM1, three different
coupled assays were carried out (Figure 1). Assay A was carried out in the presence of glucose-6P dehydrogen-
ase (G6PDH) with or without Glc-1,6-bisP as a cofactor using glucose-1P (Glc-1P) as the substrate. This assay
was carried out in a 100 ml reaction volume containing 50 mM MOPS (pH 7.4), 1.5 mM MgSO4, 1 mM DTT
(dithiothreitol), a range of Glc-1P concentrations, 1 mM NAD+, and 0.01 units of G6PDH (Sigma). The reac-
tion was started by the addition of 10 nM AfAGM1 and incubated for 60 min at 20°C. The amount of NADH
produced was measured using a ﬂuorescence reader (FL×800). Assay B was done in the presence of
UDP-N-acetylglucosamine pyrophosphorylase (UAP1) as the coupled enzyme using GlcNAc-6P as the sub-
strate as described previously [12]. The reaction mixture (100 ml) contained 50 mM MOPS (pH 7.4), 1.5 mM
MgSO4, 250 mM UTP, varying concentrations of GlcNAc-6P (2.5–300 mM), 100 nM AfAGM1, 0.5 mM
AfUAP1, and 0.04 units pyrophosphatase (Sigma) to convert the AfUAP1 reaction product inorganic pyrophos-
phate (PPi) to inorganic phosphate (Pi). The reaction was incubated at 20°C for 30 min and terminated by the
addition of 100 ml Biomol green [0.03% (w/v) malachite green, 0.2% (w/v) ammonium molybdate, and 0.5%
(v/v) Triton X-100 in 0.7 N HCl] and left for a further 20 min at 20°C for colour development. Absorbance at
620 nm was read using a spectrophotometer. Assay C involves coupling with UDP-glucose pyrophosphorylase
using glucose-6P (Glc-6P) as the substrate and the Biomol green assay as described earlier [12,25].
Table 1 Details of data collection and structure refinement
Values between the brackets are for the highest resolution shell. All measured data were
included in structure refinement.
AfAGM1–GlcNAc-6P AfAGM1_S69A–Glc-1,6-bisP
Resolution 20.00 (2.34) 20.00 (1.90)
Space group P212121 P212121
Unit cell
a (Å) 71.3 80.9
b (Å) 84.8 87.6
c (Å) 186.4 91.9
No. of reflections 183 592 191 366
No. of unique reflections 48 393 51 704
I/σ (I) 34.7 (1.8) 19.2 (2.7)
Completeness (%) 99.8 97.6
Redundancy 3.5 (3.9) 3.7 (3.6)
Rmerge (%) 5.7 (66.6) 3.4 (48.2)
RMSD from ideal geometry
Bonds (Å) 0.010 0.012
Angles (°) 1.5 2.1
Rwork (%) 21.0 16.0
Rfree (%) 27.7 20.0
No. of molecules in a.s.u 2 1
No. of residues 1036 541
No. of water molecules 297 471
B factors (Å2)
Overall 52.4 26.9
Protein 52.6 26.3
Ligand 56.4 30.6
Solvent 48.2 31.9
PDB ID 5OAW 5O9X
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Modelling and energy minimization of AfAGM1_S69A mutant–Glc-1,6-bisP
complex
To generate a model of the complex of AfAGM1 with Glc-1,6-bisP, the AfAGM1_S69A–Glc-1,6-bisP mutant
complex crystal structure was used as a template. Using COOT, the Ala69 in AfAGM1_S69A mutant was
mutated to the original Ser69 and a rotamer of Asp288 was chosen to allow coordination of the magnesium as
found in the wild-type structure with Mg2+ and GlcNAc-6P (see below). Magnesium was also incorporated in
COOT after superposition with the wild-type structure with Mg2+ and GlcNAc-6P complex, and energy mini-
mization was performed using the Schrödinger software [26]. The crystal structure was read with the Maestro
program [27], and the Protein Preparation Wizard module was used to add hydrogens, assign correct bond
orders, and solve steric conﬂicts. Once the structure was prepared, a partial minimization of hydrogen atoms
was initially performed by means of the Impact Reﬁnement module, using the OPLS-2005 force ﬁeld [27], and
ﬁnished when RMSD (root mean square deviation) reached a maximum cut-off of 0.3 Å. After this initial mini-
mization, a further total minimization including heavy atoms was also made using the same conditions and ter-
minated with an RMSD of 0.10 Å with respect to the original AfAGM1_S69A mutant–Glc-1,6-bisP complex.
Results and discussion
Ser69 is the AfAGM1 catalytic serine
Previously, we identiﬁed pSer69 as the potential catalytic residue in AfAGM1 by mass spectrometry (MS/MS),
phosphosite mapping, and crystallographic studies of the wild-type enzyme in complex with magnesium [12].
To further explore the role of the AfAGM1_pSer69 in catalysis, we determined steady-state kinetics with differ-
ent substrates in the absence and presence of Glc-1,6-bisP as the activator. The wild-type enzyme demonstrated
both N-acetylphosphoglucosamine and phosphoglucose mutase activity with Km values of 25 mM for its native
substrate GlcNAc-6P, 300 mM for Glc-6P, and 1.2 mM for Glc-1P (Table 2), demonstrating that the enzyme
speciﬁcally recognizes the N-acetyl group. We also determined the crystal structure of AfAGM1 in complex
with GlcNAc-6P and magnesium (Table 1), showing the typical four domains forming a heart shape found
previously for other members (domains 1–4, Figure 2A,B). Domains 1 (residues 1–187), 2 (residues 188–305),
3 (residues 306–442), and 4 (residues 443–542) bear the predicted active serine loop, the metal-binding loop,
the sugar-binding loop, and the phosphate-binding, respectively. The overall structure of this enzyme is similar
to that of Candida albicans N-acetylphosphoglucosamine mutase (CaAGM1) [2] (52% sequence identity,
RMSD of 1.2 Å on 496 Cα atoms) and the Pseudomonas aeruginosa phosphomannomutase/phosphoglucomu-
tase (PaPMM/PGM) [28] (20% sequence identity and RMSD of 2.3 Å on 343 Cα atoms). At the active site of
one of the two monomers in the asymmetric unit, unambiguous electron density deﬁning a phosphorylated Ser
A
B
C
Figure 1. Schematic illustrations of AfAGM1 assays.
(A) Phosphoglucomutase assay: a coupled assay with glucose-6-phosphate dehydrogenase (G6PDH) using G-1P as a
substrate. (B) Phosphoglucosamine mutase assay: a coupled assay with A. fumigatus UDP-N-acetylglucosamine
pyrophosphorylase (AfUAP1) and pyrophosphatase using GlcNAc-6P as a substrate. (C) A reverse phosphoglucomutase
assay: a coupled assay with Trypanosoma brucei UDP-glucose pyrophosphorylase (TbUGP) and pyrophosphatase using G-6P
as a substrate.
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Table 2 Kinetic parameters of AfAGM1
The coupled assay with G6PDH (Figure 1) was used to measure
AfAGM1 activity using Glc-1P as the substrate in the presence or
absence of Glc-1,6-bisP. The colorimetric assay involving purified
AfUAP1 or Trypanosoma brucei UDP-glucose pyrophosphorylase as
coupling enzymes (Figure 1) was used to measure AfAGM1 activity
using GlcNAc-6P or Glc-6P as the substrate, respectively. The results
are the mean ± SD for three determinations. Abbreviations: n.d.: not
detectable. The values for the wild-type enzyme have been reported
earlier but are shown here for comparison purposes with
AfAGM1_S69A and AfAGM1_S507A mutants [12].
Substrate WT S69A S507A
Glc-1P
Km (μM) 1200 ± 100 1900 ± 100
Vmax (μmol/s) 0.38 ± 0.01 0.138 ± 0.004
kcat (s
−1) 37.6 n.d. 13.8
Glc-1P +Glc-1,6P
Km (μM) 400 ± 30 1200 ± 100
Vmax (μmol/s) 0.41 ± 0.01 0.121 ± 0.004
kcat (s
−1) 41.0 n.d. 12.1
GlcNAc-6P
Km (μM) 25 ± 8 25 ± 9
Vmax (μmol/s) 0.021 ± 0.002 n.d. 0.008 ± 0.001
kcat (s
−1) 0.21 0.08
Glc-6P
Km (μM) 300 ± 48 2900 ± 600
Vmax (μmol/s) 0.018 ± 0.001 0.011 ± 0.001
kcat (s
−1) 0.18 n.d. 0.11
BA
Figure 2. Overall structure of AfAGM1.
(A) Overall crystal structure of one of the two monomers found in the asymmetric unit of AfAGM1–GlcNAc-6P–Mg2+ ternary
complex. Domains 1, 2, 3, and 4 are coloured in red, blue, green, and brown, respectively. The carbon sticks of
AfAGM1_pSer69 and GlcNAc-6P are coloured in yellow and grey, respectively. (B) Surface representation of the monomeric
forms of AfAGM1 in complex with GlcNAc-6P and Glc-1,6-bisP that show different conformational states during catalysis
(colours of the different domains are the same as above).
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(Ser69) was present (Figure 3A). The conformation of the phosphoserine with an O…..P–O angle of 158°
would facilitate inline attack/displacement by the GlcNAc-6P O1 and hence further supports the role of this
residue as the phosphoryl donor/acceptor (Figure 3A).
To further verify the role of S69 as the phosphoryl donor/acceptor, the S69A AfAGM1 mutant was investigated.
As expected, steady-state kinetics (Table 2) reveal that mutating Ser69 to alanine completely abolishes enzyme
activity. A similar study of human AGM1 also reported a complete loss of activity when the equivalent Ser64 was
mutated to alanine or threonine [29]. Interestingly, in a study of an equivalent mutant (Ser108Ala) in PaPMM/
PGM, another member of the same phosphohexomutase superfamily [30,31], some residual activity was reported
[31]. It was proposed that this might be the result of another residue in the active site being phosphorylated in the
absence of Ser108 [30]. We noted the proximity of Ser507 to the substrate-binding site, located in the phosphate-
binding loop (Figure 3). However, mutating the AfAGM1 S507 to alanine does not signiﬁcantly affect activity
(Table 2), suggesting that this serine does not contribute to catalysis. Thus, Ser69 is the AfAGM1 catalytic serine.
Phosphoryl transfer is associated with large conformational changes
Once it was clariﬁed that Ser69 was the only residue being phosphorylated during catalysis, we exploited this
catalytically impaired mutant to trap the bisphosphorylated intermediate that has been proposed for this class
of phosphomutase [30] (Figure 3). The protein was crystallized with Glc-1,6-bisP and the structure was reﬁned
to 1.9 Å resolution with a single protein molecule in the asymmetric unit (Table 1). The overall structure of
AfAGM1_S69A–Glc-1,6-bisP complex shows a closed conformation, compared with the open/semi-open con-
formations exhibited by the two monomers in the AfAGM1–GlcNAc-6P–Mg+2 complex (Figure 2B). Together,
these complexes reveal overall conformational changes accompanying phosphoryl transfer. Superposition of the
opened and semi-opened conformations yields an RMSD of 0.76 Å with the loop on domain 4 moving 1.4 Å
towards the active site cleft (Supplementary Figure S1). Superposition of the semi-opened and closed confor-
mations yields an RMSD of 2.1 Å with the loops on domains 1 and 4 moving 2.0 and 3.4 Å, respectively.
Superposition of the opened and closed conformations yields an RMSD of 2.3 Å with the loop on domain 4
moving 4.0 Å, while the loop on domain 1 is disordered in the opened conformation structure (Supplementary
Figure S1). Thus, domain 4 of the enzyme appears to be mobile, closing, or opening the active site in response
to interactions between the enzyme and its substrates/products/intermediate. We have visualized this with a
video that has been included in Supplementary Figure S2. The dephospho-AfAGM1–GlcNAc-6P complex has
an overall structure with an open active site (Figure 2B) and may represent the inactive enzyme or ‘apo’ like
conformation. This complex provides the likely snapshot of the conformation of the protein just before the ﬁrst
phosphoryl transfer or the release of product from the active site. However, the inactive AfAGM1_S69A
mutant–Glc-1,6-bisphosphate complex has an overall structure with a closed active site (Figure 2B) and repre-
sents the reaction intermediate with Glc-1,6-bisphosphate buried in the active pocket. This is the ﬁrst crystallo-
graphic evidence of the structural changes by this class of enzymes during catalysis, which corroborates the
reaction mechanism proposed by Regni et al. [28]. The complete closure of the active site is achieved by the
establishment of extensive hydrogen bond interactions between the reaction intermediate Glc-1,6-bisphosphate
and the protein (Figure 3). While the 1-phosphate group of the ligand pointing to Ala69 occupies partly the
position of the phosphoserine observed in the AfAGM1_S69A–Glc-1,6-bisP complex, the 6-phosphate group is
located in the phosphate-binding domain. In addition, the 1-phosphate group establishes hydrogen bond inter-
actions with R33, H70, R289 and a water molecule, the 6-phosphate group makes hydrogen bond interactions
with T29, R505, S507, T509, R514 and the backbone of G508, and the 3-OH and 4-OH groups of the sugar
make hydrogen bond interactions with E380 and the backbone of V363 (Figure 3). Thus, extensive hydrogen
bond interactions are established with residues from all the domains resulting in a closed conformation
(Figure 2B). This provides a snapshot of the reaction either immediately after phosphoryl transfer to form the
intermediate or before the second phosphoryl transfer to re-phosphorylate the enzyme. The
phospho-AfAGM1–GlcNAc-6P–Mg2+ Michaelis complex reveals a semi-opened active site and may represent
the active complex. For this complex, it was observed that GlcNAc-6P made hydrogen bond interactions with
residues R505, R514, S507, T509, G508, E380 and V363 from domains 3 and 4 of the protein but not with any
residues from domains 1 and 2. Furthermore, the AfAGM1_pSer69 establishes hydrogen bond interactions
with residues R33, R289 and H70 from domains 1 and 2 as well as Mg2+, which is co-ordinated by D288,
D284 and D286 (Figure 3); hence, domains 3 and 4 relax to open the active site cleft (Figure 2B). Although
these interactions are different from the previously determined CaAGM1–GlcNAc-6P–Zn2+–P or CaAGM1–
GlcNAc-1P–Zn2+_P complex [2] which shows extensive hydrogen bond interactions with residues from all the
© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).2552
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domains (Figure 3), the phospho-AfAGM1–GlcNAc-6P–Mg2+ complex may represent a snapshot of the con-
formation that supports the proposed reorientation of the intermediate or conformation just before the ﬁrst
phosphoryl transfer (Figure 2B). It is likely that for the reorientation of the intermediate to occur, the domains
have to be relaxed from the closed state to the semi-open conformation (Figure 2B) allowing the reorientation
of the intermediate without leaving the enzyme active site. In summary, these structures reveal that phosphoryl
transfer is associated with large conformational changes.
The catalytic role of Ser69 depends on its coordination to a magnesium ion
AGM belongs to the α-D-phosphohexomutase metalloenzyme superfamily and the magnesium ion is essential
for catalysis [16]. Structures of related phosphohexomutases in complex with substrates/products or the
Figure 3. Active sites of AfAGM1 and CaAGM1 in complex with different ligands.
The active sites of AfAGM1–GlcNAc-6P–Mg2+ and AfAGM1_S69A–Glc-1,6-bisP complexes are compared with CaAGM1–
GlcNAc-6P–Zn2+-phosphate (PDB 2DKC) and CaAGM1–GlcNAc-1P–Zn2+-phosphate (PDB 2DKD) complexes [2]. Carbon
atoms of residues within the active site pocket and sugars are shown as grey and green sticks, respectively. Mg2+ and Zn2+
ions, and water molecules are shown as pink, yellow, and blue spheres, respectively. Hydrogen bond interactions between the
protein and the ligands are shown as black dashed lines, while Mg2+ and Zn2+ co-ordinations are shown as brown dash lines.
The |Fo|− |Fc|, wcalc electron density maps around the ligands are shown contoured at 2.5 σ and also the ﬁnal 2|Fo|− |Fc|
electron density map for the phosphorylated active Ser69 is shown, contoured at 1.0 σ. A black arrow indicates the inline angle
of attack of 158° of 1-hydroxyl of GlcNAc-6P on the phosphate located in AfAGM1_pSer69.
© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). 2553
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bisphosphosugar intermediate have been described, but they have not provided a detailed understanding of the
atomic trajectories during catalysis [28,32]. In this work, we have obtained two different complexes that repre-
sent distinct steps of the catalytic cycle. At the active site level, both pSer69 and phosphate group either present
in Glc-1,6-bisP or as a free phosphate in CaAGM1 [2] interact by electrostatic interactions and hydrogen bonds
with conserved residues such as Arg33, His70, Arg289, and H384 (Figure 3; in CaAGM1 these residues corres-
pond to Arg30, His67, Arg295, and His391, respectively). His384 (His391 in CaAGM1) is the only residue
adopting on and off conformations that supports the concept of ‘near attack conformers (NACs)’ present in
other members of this superfamily [13]. These conformers exist to avoid repulsion among highly charged resi-
dues and consequently to optimize catalytic turnover [13]. In the case of AGM1, this histidine may switch
from an off to an on conformation to activate the O-1 hydroxyl group of the GlcNAc-6P that would subse-
quently attack the phosphate atom (Figure 3). Furthermore, the phosphate group is co-ordinated either by a
magnesium ion (see the phospho-AfAGM1–GlcNAc-6P–Mg2+ complex in Figure 3), which is needed in turn
to have an active enzyme, or a zinc ion acting as an AGM1 inhibitor (see the CaAGM1–ligand complexes in
Figure 3) [2]. In AfAGM1, the magnesium ion is pentagonally co-ordinated in a square pyramidal arrangement
by AfAGM1_pSer69, Asp284, Asp286, and Asp288 (Figure 3). This type of coordination has also been
described for the structure of CaAGM1 complexed with either GlcNAc-1P or GlcNAc-6P and zinc acting as an
inhibitor (Figure 3) [2]. Although the inactive AfAGM1_S69A mutant–Glc-1,6-bisphosphate complex was crys-
tallized in the presence of 10 mM MgCl2, the structure (Figure 3) reveals the absence of this metal and the
presence of a water molecule instead (Figure 3). The magnesium ion helps to stabilize the charges and hence
facilitates the transfer of phosphoryl group between the AfAGM1_pSer69 and the O1 or O6 of the substrates
[2,33]. The catalytic serine is, however, key in the coordination to the magnesium ion throughout the catalytic
cycle and therefore constitutes an essential feature for having a functional AGM1.
The phosphate group as the putative catalytic base
Previous work on pSer-dependent phosphohexomutases combined with the two new structures shown in this
study do identify the amino acids that may be required for activation of the O1/O6 hydroxyls groups.
Inspection of some of the amino acids interacting with the phosphoserine, the Glc-1,6-bisP, or the free phos-
phate present in the CaAGM1 [2] reveals many candidates that may fulﬁl this role. For instance, His70 or
His384 and Arg33 that form hydrogen bond interactions with 1P group of Glc-1,6-bisP and phosphate group
of AfAGM1_pSer69 (Figure 3) could act as activators. Another alternative is that both the hydroxyl group from
Ser69 and the O1/O6 hydroxyls from GlcNAc-1P/6P act as a nucleophile in the absence of a catalytic base,
although this is unlikely given the proximity of the positive charge on the magnesium ion. To further explore
this, we made a model of the wild-type enzyme complexed with magnesium and Glc-1,6-bisP based on the
structure of the inactive mutant reported here (Figure 4A). The template was used because it approximates the
reaction intermediate catalytic step (Figure 3). Interestingly, this model suggests that the phosphates may
uptake the proton from the hydroxyl group of Ser69 leading to an increase of nucleophilicity of the serine side
chain that is required to attack the phosphate. One of the pKas of this phosphate group is ∼6.8, which makes it
compatible with its potential role as a catalytic base and further supports the proposed mechanism (Figure 4B).
In this scenario, GlcNAc-6P enters the active site and the oxyanion of 1-hydroxyl from GlcNAc-6P is precisely
formed once it is located in front of AfAGM1_pSer69 by proton uptake by the phosphate group. In this
manner, negative repulsion of the substrate and AfAGM1_pSer69 would be avoided and the reaction will only
take place when both are correctly positioned. GlcNAc-1,6-bisP (N-acetylglucosamine-1,6-bisphosphate) would
be formed and the required ﬂip over around the O5–C3 axis will render the 6-phosphate group in a position to
be transferred to Ser69 by the same mechanism proposed (Figure 4B). Finally, GlcNAc-1P is formed, complet-
ing the catalytic cycle.
Conclusions
N-acetylphosphoglucosamine mutase is a key enzyme of the hexosamine biosynthetic pathway in eukaryotes.
The enzyme catalyzes the interconversion of GlcNAc-6P to GlcNAc-1P, which is subsequently converted to
UDP-GlcNAc by UDP-GlcNAc pyrophosphorylase, the last enzyme in the pathway. UDP-GlcNAc is the direct
precursor for many cellular processes, for instance, in fungi, it is used in the synthesis of chitin that forms the
major component of the fungi cell wall and it is thus believed that enzymes involved in its synthesis are poten-
tial drug targets [3,34,35]. The results presented here have helped our understanding of the catalytic mechan-
ism of AfAGM1 and the wider phosphohexomutase superfamily. AfAGM1 shares the same overall structure
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with other members of this superfamily although it is more similar to CaAGM1 [2] (RMSD 1.2 Å) than to
phosphomannomutase/phosphoglucomutase (RMSD 2.3 Å). Although the crystal structure of the well-
characterized member of the phosphohexomutase superfamily PaPMM/PGM with phosphorylated active
Ser108 has been reported, here we describe the ﬁrst crystal structure of a member of the phosphoacetylglucosa-
mine mutase subfamily with phosphorylated active Ser69 (Figure 2A). This post-translational modiﬁcation
occurs during expression in E. coli by an as-yet-unknown mechanism which may involve autophosphorylation
in the presence of ATP [17]. The kinetic characterization of the enzyme reveals that the enzyme possesses both
phosphoglucomutase and phosphoacetylglucosamine mutase activity. The enzyme is capable of interconverting
Glc-1P to Glc-6P, GlcNAc-6P to GlcNAc-1P, and Glc-6P back to Glc-1P but with different rate constants and
GlcNAc-6P as the preferred substrate (Table 2). The structural complexes described in this study reveal that
the enzyme adopts large conformational changes along the catalytic cycle. Thus, the active site of the
dephospho-AfAGM1-GlcNAc-6P is open, representing an inactive state of the enzyme while the
phospho-AfAGM1-GlcNAc-6P–Mg2+ adopts a semi-opened active site representing the active Michaelis
complex. This complex, however, reveals that the mechanism of phosphoryl transfer from the active serine to
the acceptor substrate might be due to the formation of an oxyanion of the 1-hydroxyl of GlcNAc-6P by
proton uptake from AfAGM1_pSer69. Hence, a mechanism of phosphoryl transfer involving the ionization of
the acceptor substrate by the phosphate acting as the catalytic base is the most plausible mechanism. In conclu-
sion, these enzymes suffer large conformational changes, mainly in domain 4, which in turn are coupled to a
precise phosphate-assisted mechanism in which phosphate may act as the catalytic base. The understanding of
the catalytic mechanism can therefore be exploited in the rational design of a mechanism-inspired inhibitors
which are lacking for this class of enzymes.
Abbreviations
AfAGM1, A. fumigatus AGM1; AGM1, N-acetylphosphoglucosamine mutase; CaAGM1, Candida albicans
N-acetylphosphoglucosamine mutase; G6PDH, glucose-6P dehydrogenase; Glc-1P, glucose-1P; Glc-6P,
glucose-6P; GlcNAc-6P, N-acetylglucosamine-6-phosphate; PaPMM/PGM, Pseudomonas aeruginosa
phosphomannomutase/phosphoglucomutase; RMSD, root mean square deviation; UAP1,
UDP-N-acetylglucosamine pyrophosphorylase.
BA
Figure 4. Catalytic mechanism.
(A) Model of wild-type AfAGM1 active site in complex with Glc-1,6-bisP and magnesium. Colours are the same as Figure 3 and
a hydrogen atom bound to Ser69 is shown in yellow. (B) Scheme of the proposed reaction mechanism of
phosphoacetylglucosamine mutase.
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